![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Once-daily alisporivir interferon (IFN)-free regimens achieve high rates of early HCV clearance in previously untreated patients with HCV genotype (G) 2 or 3
|
|
|
Reported by Jules Levin
AASLD
Nov 5-9 2011 SF
JM Pawlotsky1, R Flisiak2, J Rasenack3, SK Sarin4, T Piratvisuth5, WL Chuang6, GR Foster7, H Wedemeyer8, C Hezode1, W Zhang9, C Avila10, NV Naoumov10
1Hopital Henri Mondor, Creteil, France; 2Medical University, Biaystok, Poland; 3Albert Ludwigs University, Freiburg, Germany; 4Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India; 5NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand; 6Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 7Queen Mary, University of London, Bart's and The London School of Medicine, London, UK; 8Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany; 9Beijing Novartis Pharma Co. Ltd., Shanghai, China; 10Novartis Pharma AG, Basel, Switzerland
![AASLD1.gif](../images/110911/110911-5/AASLD1.gif)
![AASLD2.gif](../images/110911/110911-5/AASLD2.gif)
![AASLD3.gif](../images/110911/110911-5/AASLD3.gif)
![AASLD4.gif](../images/110911/110911-5/AASLD4.gif)
![AASLD5.gif](../images/110911/110911-5/AASLD5.gif)
![AASLD6.gif](../images/110911/110911-5/AASLD6.gif)
![AASLD7.gif](../images/110911/110911-5/AASLD7.gif)
![AASLD8.gif](../images/110911/110911-5/AASLD8.gif)
![AASLD9.gif](../images/110911/110911-5/AASLD9.gif)
![AASLD10.gif](../images/110911/110911-5/AASLD10.gif)
![AASLD11.gif](../images/110911/110911-5/AASLD11.gif)
![AASLD12.gif](../images/110911/110911-5/AASLD12.gif)
![AASLD13.gif](../images/110911/110911-5/AASLD13.gif)
![AASLD14.gif](../images/110911/110911-5/AASLD14.gif)
![AASLD15.gif](../images/110911/110911-5/AASLD15.gif)
![AASLD16.gif](../images/110911/110911-5/AASLD16.gif)
![AASLD17.gif](../images/110911/110911-5/AASLD17.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|